A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE FOR THE USE FOR THE TREATMENT OF RENAL CELL CARCINOMA (RCC)

신장 세포 암종 (RCC) 의 치료를 위해 사용되기 위한 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용가능한 염 및/또는 용매화물. 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or sol...

Full description

Saved in:
Bibliographic Details
Main Authors BLADT FRIEDHELM, FRIESE HAMIM MANJA
Format Patent
LanguageEnglish
Korean
Published 22.08.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:신장 세포 암종 (RCC) 의 치료를 위해 사용되기 위한 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용가능한 염 및/또는 용매화물. 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof for the use for the treatment of renal cell carcinoma (RCC).
Bibliography:Application Number: KR20167021524